Meetings and Workshops

Upcoming Meetings and Workshops

The Office of Environmental Health Hazard Assessment (OEHHA) will host an online pre-regulatory workshop to discuss a potential set of amendments related to vinyl acetate to existing Proposition 65 regulations on September 30, 2026.
-
OEHHA is referring ethoprop to the Carcinogen Identification Committee for a recommendation concerning whether the chemical should continue to be included on the list of chemicals known to the state to cause cancer.
-

Previous Meetings and Workshops

Extension of comment period on the notice of intent to list nitrite in combination with amines or amides as known to the State to cause cancer.

to

Announcement of a public workshop to be held on April 14, 2014 for the purpose of discussing a possible regulatory action to change the existing regulation governing Proposition 65 warnings.

to

Comment period on the Notice of intent to list pentosan polysulfate sodium, pioglitazone, triamterene as known to cause cancer by the Labor Code mechanism

to

Comment period on the notice of intent to list: Atrazine, propazine, simazine and their chlorometabolites DACT, DEA and DIA.

to

Notice of intent to list Megestrol acetate as known to the state to cause cancer under the "Formally Required to Be Labeled or Identified" listing mechanism.

to

Extension of the comment period on the notice of intent to list nitrite in combination with amines or amides.

to

Comment period for the notice of intent to list beta-myrcene

to

Comment period on the Notice of intent to list pulegone as known to the State to cause cancer via the Labor Code mechanism

to

Comment Period on the Proposal to add section 25904 to Title 27, Cal. Code of Regulations.  This regulation would clarify the procedure and criteria OEHHA uses to list and de-list chemicals via the “Labor Code” listing mechanism of Proposition 65.

to

Comment Period - Notice of Modification to Text of Proposed Regulation Title 27, California Code of Regulations Proposed Amendment to Section 25302, Science Advisory Board And Section 25304, Financial Disclosure

to